_version_ 1784849889807564800
author Ghorbanalipoor, Saeedeh
Emtenani, Shirin
Parker, Melissa
Kamaguchi, Mayumi
Osterloh, Colin
Pigors, Manuela
Gross, Natalie
Khil’chenko, Stanislav
Kasprick, Anika
Patzelt, Sabrina
Wortmann, Diana
Ibrahim, Ibrahim O.
Izumi, Kentaro
Goletz, Stephanie
Boch, Katharina
Kalies, Kathrin
Bieber, Katja
Smith, Paul
Schmidt, Enno
Ludwig, Ralf J.
author_facet Ghorbanalipoor, Saeedeh
Emtenani, Shirin
Parker, Melissa
Kamaguchi, Mayumi
Osterloh, Colin
Pigors, Manuela
Gross, Natalie
Khil’chenko, Stanislav
Kasprick, Anika
Patzelt, Sabrina
Wortmann, Diana
Ibrahim, Ibrahim O.
Izumi, Kentaro
Goletz, Stephanie
Boch, Katharina
Kalies, Kathrin
Bieber, Katja
Smith, Paul
Schmidt, Enno
Ludwig, Ralf J.
author_sort Ghorbanalipoor, Saeedeh
collection PubMed
description
format Online
Article
Text
id pubmed-9748735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97487352022-12-15 Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases Ghorbanalipoor, Saeedeh Emtenani, Shirin Parker, Melissa Kamaguchi, Mayumi Osterloh, Colin Pigors, Manuela Gross, Natalie Khil’chenko, Stanislav Kasprick, Anika Patzelt, Sabrina Wortmann, Diana Ibrahim, Ibrahim O. Izumi, Kentaro Goletz, Stephanie Boch, Katharina Kalies, Kathrin Bieber, Katja Smith, Paul Schmidt, Enno Ludwig, Ralf J. Front Immunol Immunology Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9748735/ /pubmed/36532003 http://dx.doi.org/10.3389/fimmu.2022.1099535 Text en Copyright © 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil’chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ghorbanalipoor, Saeedeh
Emtenani, Shirin
Parker, Melissa
Kamaguchi, Mayumi
Osterloh, Colin
Pigors, Manuela
Gross, Natalie
Khil’chenko, Stanislav
Kasprick, Anika
Patzelt, Sabrina
Wortmann, Diana
Ibrahim, Ibrahim O.
Izumi, Kentaro
Goletz, Stephanie
Boch, Katharina
Kalies, Kathrin
Bieber, Katja
Smith, Paul
Schmidt, Enno
Ludwig, Ralf J.
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
title Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
title_full Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
title_fullStr Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
title_full_unstemmed Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
title_short Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
title_sort corrigendum: cutaneous kinase activity correlates with treatment outcomes following pi3k delta inhibition in mice with experimental pemphigoid diseases
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748735/
https://www.ncbi.nlm.nih.gov/pubmed/36532003
http://dx.doi.org/10.3389/fimmu.2022.1099535
work_keys_str_mv AT ghorbanalipoorsaeedeh corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT emtenanishirin corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT parkermelissa corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT kamaguchimayumi corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT osterlohcolin corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT pigorsmanuela corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT grossnatalie corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT khilchenkostanislav corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT kasprickanika corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT patzeltsabrina corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT wortmanndiana corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT ibrahimibrahimo corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT izumikentaro corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT goletzstephanie corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT bochkatharina corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT kalieskathrin corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT bieberkatja corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT smithpaul corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT schmidtenno corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases
AT ludwigralfj corrigendumcutaneouskinaseactivitycorrelateswithtreatmentoutcomesfollowingpi3kdeltainhibitioninmicewithexperimentalpemphigoiddiseases